Your browser doesn't support javascript.
loading
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
William, William N; Zhang, Jianjun; Zhao, Xin; Parra, Edwin R; Uraoka, Naohiro; Lin, Heather Y; Peng, S Andrew; El-Naggar, Adel K; Rodriguez-Canales, Jaime; Song, Jaejoon; Gillenwater, Ann M; Wistuba, Ignacio I; Myers, Jeffrey N; Gold, Kathryn A; Ferrarotto, Renata; Hwu, Patrick; Davoli, Teresa; Lee, J Jack; Heymach, John V; Papadimitrakopoulou, Vassiliki A; Lippman, Scott M.
  • William WN; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhang J; Hospital BP, a Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
  • Zhao X; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Parra ER; Department of Biochemistry and Molecular Pharmacology, Institute for Systems Genetics, New York University Langone Health, New York, New York, USA.
  • Uraoka N; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lin HY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Peng SA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • El-Naggar AK; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Rodriguez-Canales J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gillenwater AM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wistuba II; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Myers JN; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gold KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ferrarotto R; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.
  • Hwu P; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Davoli T; Moffitt Cancer Center, Tampa, Florida, USA.
  • Lee JJ; Department of Biochemistry and Molecular Pharmacology, Institute for Systems Genetics, New York University Langone Health, New York, New York, USA.
  • Heymach JV; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Papadimitrakopoulou VA; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lippman SM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cancer ; 129(5): 714-727, 2023 03 01.
Article en En | MEDLINE | ID: mdl-36597662

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Neoplasias de Cabeza y Cuello Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Neoplasias de Cabeza y Cuello Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article